Synthesis and antitumor properties of new 2,4-dichlorophenoxy ethers

被引:0
作者
B. F. Abdel-Wahab
M. Farghaly
F. A. Badria
机构
[1] National Research Center,Applied Organic Chemistry Department
[2] Mansoura University,Pharmacognosy Departments, Faculty of Pharmacy
来源
Pharmaceutical Chemistry Journal | 2011年 / 45卷
关键词
2,4-dichlorophenoxyacetic acid; imidazo[2,1-b][1,3,4]thiadiazoles; pyrazoles; hydrazonoyl chlorides; thiosemicarbazides; 1,3,4-thiadiazoles; antitumor activity;
D O I
暂无
中图分类号
学科分类号
摘要
A series of new compounds incorporating 2,4-dichlorophenoxy nucleus have been synthesized. Reaction of 2,4-dichlorophenoxyacetic acid with thiosemicarbazide in the presence of phosphoryl chloride followed by treatment with phenacylbromides led to the formation of imidazo[2,1-b][1,3,4]thiadiazoles (3). Bischlorophenoxyallyl hydrazides (4) reacted with some of alkenes, azo dyes, aldehydes, and hydrazonoyl chlorides to produce pyrazoles, Schiff bases, and bis-diazo compounds, respectively. 1,3,4-Thiadiazole (10) was obtained by reaction of dichlorophenoxyallyl hydrazides (4b) with carbon disulphide followed by hydrazonoyl chlorides. All compounds were tested for their preliminarily antitumor activity on transplantable murine tumor cell line [Ehrlich ascites carcinoma (EAC)]. Compound 2-{2-[2-(2,4-dichlorophenoxy)acetyl]hydrazono}-N'-(4-fluorophenyl)propanehydrazonoyl chloride (8c) has remarkably decreased the viable EAC cell count as indicated by Trypan Blue dye exclusion test (3%) in comparison to the well known antitumor agent 5-FU (0%).
引用
收藏
页码:30 / 35
页数:5
相关论文
共 86 条
  • [1] Shi YN(1995)undefined Chem. J. Univ. (Chinese) 16 1710-1713
  • [2] Lu YC(1991)undefined Chem. Pharm. Bull. 39 2681-2690
  • [3] Fang JX(1969)undefined J. Med. Chem. 12 677-680
  • [4] Hua YL(1992)undefined J. Indian Chem. Soc. 69 402-409
  • [5] Kitagawa M(1988)undefined Chem. J. Chin. Univ. (Chinese) 9 584-591
  • [6] Yamamoto K(1987)undefined J. Heterocycl. Chem. 24 1173-1182
  • [7] Katakura S(2008)undefined Arch. Pharm. 341 734-739
  • [8] Kanno H(1996)undefined Farmaco 51 811-814
  • [9] Yamada K(1996)undefined Farmaco 51 71-74
  • [10] Baker BR(2009)undefined Eur. J. Med. Chem. 44 2632-2635